BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 20 filers reported holding BIOPHARMX CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $17,000 | -39.3% | 58,027 | 0.0% | 0.01% | -37.5% |
| Q2 2017 | $28,000 | +100.0% | 58,027 | +107.0% | 0.01% | +100.0% |
| Q1 2017 | $14,000 | +40.0% | 28,027 | 0.0% | 0.00% | +33.3% |
| Q4 2016 | $10,000 | -37.5% | 28,027 | 0.0% | 0.00% | -40.0% |
| Q3 2016 | $16,000 | – | 28,027 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 12,814,286 | $6,471,000 | 1.90% |
| RTW INVESTMENTS, LP | 1,283,951 | $648,000 | 0.17% |
| Sio Capital Management, LLC | 313,717 | $158,000 | 0.09% |
| DAFNA Capital Management LLC | 115,000 | $58,000 | 0.05% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 28,027 | $14,000 | 0.00% |
| Baker Brothers Advisors | 377,295 | $191,000 | 0.00% |
| Virtu KCG Holdings LLC | 107,994 | $55,000 | 0.00% |
| FRANKLIN RESOURCES INC | 9,499,615 | $4,797,000 | 0.00% |
| Moors & Cabot, Inc. | 13,000 | $7,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 17,274 | $8,000 | 0.00% |